In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals

被引：14
|
作者：
Tumino, Nicola [1 ]
Casetti, Rita [1 ]
Fabbri, Gabriele [2 ]
Cimini, Eleonora [1 ]
Romanelli, Antonella [1 ]
Turchi, Federica [1 ]
Forini, Olindo [1 ]
Bordoni, Veronica [1 ]
Antinori, Andrea [2 ]
Ammassari, Adriana [2 ]
Sacchi, Alessandra [1 ]
Agrati, Chiara [1 ]
机构：
[1] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Dept Epidemiol Preclin Res & Adv Diagnost, Rome, Italy
[2] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Dept, Rome, Italy
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 67卷 / 02期
关键词：
CHRONIC HEPATITIS-C; ANTIRETROVIRAL THERAPY; CLINICAL-SIGNIFICANCE; COINFECTED PATIENTS;
D O I：
10.1016/j.jhep.2017.03.036
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：422 / 424
页数：4
相关论文
共 50 条
  • [1] Reply to: "In HIV/HCV co-infected patients T regulatory and myeloid derived suppressor cells persist after successful treatment with directly acting antivirals"
    Langhans, Bettina
    Spengler, Ulrich
    JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 424 - 425
  • [2] Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
    Mohamed, Inas E. L-Khedr
    EL-Saeed, Kadry Mohamed
    Al-Sadik, Mahmoud Hassan
    Anwar, Christina Alphonse
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [3] Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
    Inas E L-Khedr Mohamed
    Kadry Mohamed EL-Saeed
    Mahmoud Hassan Al-Sadik
    Christina Alphonse Anwar
    Egyptian Liver Journal, 11
  • [4] Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals
    Rockstroh, Juergen K.
    LIVER INTERNATIONAL, 2015, 35 : 51 - 55
  • [5] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
    L. Dold
    C. Schwarze-Zander
    C. Boesecke
    R. Mohr
    B. Langhans
    J.-C. Wasmuth
    C. P. Strassburg
    J. K. Rockstroh
    U. Spengler
    Scientific Reports, 9
  • [6] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
    Dold, L.
    Schwarze-Zander, C.
    Boesecke, C.
    Mohr, R.
    Langhans, B.
    Wasmuth, J-C
    Strassburg, C. P.
    Rockstroh, J. K.
    Spengler, U.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Lipid Profiles After Therapy with Direct-Acting Antivirals in HCV Mono-infected and HCV/HIV Co-infected Patients
    Simmons, Okeefe L.
    Drechsler, Henning
    Kouma, Marcus
    Brown, Geri
    Bedimo, Roger
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S343 - S343
  • [8] Liver fibrosis evolution after hepatitis C treatment with direct acting antivirals (DAA) in co-infected patients HCV/HIV
    Mendez, J.
    Videira Santos, F.
    Cipriano, A.
    Soeiro, C.
    Valdoleiros, S.
    Goncalves, C.
    Tavares, A. P.
    Castro, R. Sarmento E.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 241 - 241
  • [9] Directly active antivirals pharmacokinetics in HCV/HIV co-infected patients with advanced hepatic fibrosis
    Marinaro, L.
    Merli, M.
    Barco, A.
    Alcantarini, C.
    Montrucchio, C.
    Tettoni, M. C.
    Vendemiati, G.
    Bocchino, G.
    De Nicolo, A.
    Hasson, H.
    D'Avolio, A.
    Foppa, C. U.
    Di Perri, G.
    Bonora, S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S534 - S534
  • [10] Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients
    Carrasco, Itziar
    Sainz, Talia
    Antoinette Frick, Marie
    Jimenez de Ory, Santiago
    Fortuny, Claudia
    Burgos, Joaquin
    Montero, Marta
    Gavilan, Cesar
    Dolores Falcon, Maria
    Antonio Couceiro, Jose
    Ignacio Bernardino, Jose
    Bisbal, Otilia
    Guerrero, Carmelo
    Teresa Aldamiz-Echevarria, Maria
    Berenguer, Juan
    Luisa Navarro, Maria
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (09) : 955 - 958
12345